Seafood authenticity research moves into new stage
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
Showing 181 - 200 of 422 results
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA
A large collaboration of Australian and New Zealand researchers has established that a thin film technology can be used to monitor stormwater effectively and provides a way to translate the presence of metal contaminants into potential risks to aquatic ecosystems.
The Australian led regional cancer care project in medical physics held its first regional training course in Malaysia to progress Rays of Hope.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
To celebrate International Women’s Day, ANSTO opened its doors to more than 50 female STEM students who heard from two accomplished ANSTO’s female scientists and STEM champions.
The first pilot project at the Australian Synchrotron takes place following a Memorandum of Understanding between nandin and Swinburne University of Technology and Design Factory Melbourne (DFM).
ANSTO scientists share approach on the global stage at the IAEA General Conference.
Australia’s new Mo-99 manufacturing facility reaches practical completion
Highlighted at radiation protection congress
Southern Cross researcher Dr Alana Gall, who recently became an ANSTO research Fellow, has been awarded more than $640,000 to lead a research program focused on First Peoples' Cultural Medicines (also called bush medicine) in Australian healthcare.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
For over 45 years, ANSTO has provided consultancy and process development services to the mining and minerals processing industries in Australia and globally.
Role at ANSTO